GTIC
0.1180
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
71.56KP/E (TTM)
-Basic EPS (TTM)
-0.09Dividend Yield
0%Recent Filings
10-Q
Q2 FY2026 results
Greentech Innovations narrowed its Q2 net loss to $14,121 from $11,927 y/y, driven by higher professional fees that lifted operating expenses 48% to $6,753, while interest expense held steady at $7,368; YTD losses shrank 11% to $32,718 from $36,913 as professional fees dropped. No revenue yet, with losses funded by $14,650 director advances matching $14,650 operating cash burn. Convertible notes total $129,402 at 25% rates, due on demand, plus $184,157 accrued interest; stockholders' deficit hit $467,081. EPS reconciles at $(0.02) on 606,475 shares. Disclosure controls ineffective. Funding shortfall looms large.
10-Q
Q1 FY2026 results
GreenTech Innovations narrowed its Q1 FY2026 net loss to $18,597 from $24,986 y/y, as operating expenses dropped 36% to $11,149—driven by lower professional fees—while interest expense held at $7,448. Losses per share improved to $(0.03) from $(0.04) on steady 606,475 diluted shares. Cash burn eased to $12,350 from operating activities, fully offset by director advances; zero cash balances persist alongside $129,402 convertible notes (25% rate, demand due) and $453K current liabilities. No revenue yet. Disclosure controls falter.
10-K
FY2025 results
Greentech Innovations posted FY2025 net loss of $60,650, down 7% y/y from $65,101, as operating expenses fell 12% to $31,099 on lower professional fees—yet zero revenue persisted. Interest expense on $129,402 convertible notes held steady near $29,600 annually, pushing total liabilities to $434,363 with no cash. Director advances of $29,298 funded operations, trimming cash burn from prior year. No quarterly breakdowns disclosed. Losses mount. Going concern hinges on financing.
10-Q
Q3 FY2025 results
Startech Labs narrowed its Q3 FY2025 net loss to $11,786 from $13,317 y/y, a 11% drop, while operating expenses fell 24% to $4,500 on lower professional fees. Nine-month net loss improved to $48,699 from $53,704 y/y (9% better), with operating loss at $26,597 (down 16%). Interest expense held steady, widening the gap between operating and net loss. No cash on hand; director advanced $26,795 to cover $26,795 operating cash burn, pushing liabilities to $422,412 including $129,402 convertible notes at 25% rates. Losses shrink steadily. Going concern doubts linger.
10-Q
Q2 FY2025 results
Startech Labs narrowed its Q2 net loss to $11,927 from $13,601 y/y, while operating expenses dropped 27% to $4,559 on lower professional fees; six-month net loss improved 9% to $36,913 versus prior year. No revenue yet, but costs shrank steadily. Cash stayed at zero, fully funded by $17,681 director advance matching $17,681 operating outflow—down from $22,617 y/y. Convertible notes held at $129,402 (25% rates, demand due), with $154,606 accrued interest; stockholders' deficit widened to $410,626. Disclosure controls ineffective. Funding remains precarious.
ASFT
APPSOFT TECHNOLOGIES INC
0.27+0.00
FYNN
Fyntechnical Innovations, Inc.
0.00+0.00
GBUX
GIVBUX INC.
0.05-0.02
GMTH
GMTECH INC.
0.10+0.05
GTCH
GBT Technologies Inc.
0.00-0.00
GTLL
Global Technologies, Ltd.
0.00-0.00
NXTT
Next Technology Holding Inc.
6.73-0.17
STEC
Santech Holdings Limited
0.96-0.07
VIA
Via Transportation, Inc.
30.18+0.87
WBSR
Webstar Technology Group Inc.
0.07+0.02